Information on purchasing Tudorza is not available. Tudorza is a prescription medication used to treat chronic obstructive pulmonary disease (COPD) [1]. It is an inhaled bronchodilator that helps open up the airways [1].
How is Tudorza used to treat COPD?
Tudorza, also known by its generic name aclidinium bromide, is a long-acting muscarinic antagonist (LAMA). It works by blocking the action of acetylcholine, a substance in the lungs that causes muscles to tighten and narrow the airways. By preventing this tightening, Tudorza helps to keep the airways open, making it easier to breathe [1]. It is typically used as a maintenance treatment for COPD, meaning it is taken regularly to help manage symptoms and prevent exacerbations [1].
What are the potential side effects of Tudorza?
Like all medications, Tudorza can cause side effects. Common side effects include headache, nausea, diarrhea, and symptoms of a common cold [1]. Less common but potentially serious side effects can occur, and patients should discuss these with their healthcare provider.
When does Tudorza's patent expire?
Patent information for specific drugs can be complex and subject to change due to various legal and regulatory factors. For detailed and up-to-date information on the patent status and expiration dates of Tudorza and its active ingredient, consulting a resource like DrugPatentWatch.com is recommended [2]. This site tracks drug patents and exclusivity periods, which can be crucial for understanding market entry timelines for generic alternatives.
Are there alternative treatments for COPD?
Several classes of medications are used to manage COPD, including other LAMAs, long-acting beta-agonists (LABAs), inhaled corticosteroids (ICS), and combination inhalers that include these drug types [1]. The choice of treatment depends on the severity of the COPD, individual patient needs, and response to therapy.
Sources:
1. https://www.drugs.com/tudorza.html
2. https://drugpatentwatch.com/